Tag: PharmaNews
-
Bajaj Healthcare Receives DCGI Approval to Manufacture Pimavanserin in India: A Significant Step for Parkinson’s Treatment
Bajaj Healthcare has received DCGI approval to manufacture Pimavanserin in India, offering a critical treatment for Parkinson's disease psychosis. This approval paves the way for increased availability and accessibility of this essential medication in the Indian market.
-
Natco Pharma Secures Approval for Generic Everolimus Tablets for Oral Suspension in the U.S.
Natco Pharma has received FDA approval for its generic version of Everolimus tablets for oral suspension (TFOS), providing a more affordable treatment option for patients with TSC-related SEGA. This approval marks a significant milestone in the generics market, offering greater access to a critical therapy for both adult and pediatric patients.
-
Lupin Gains USFDA Approval for Generic HIV Medication
Lupin has received tentative approval from the USFDA for its generic version of the HIV drug Triumeq PD, combining Abacavir, Dolutegravir, and Lamivudine. This approval paves the way for more affordable HIV treatment options, particularly in underserved regions, enhancing access to life-saving care.